Dimethylformamide

Dimethylformamide

SCHEMBL325522

CN(C)C=O.[H-].[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Dimethylformamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003029251-A1 NOVEL PROCESS FOR THE SYNTHESIS OF THIAZOLIDINEDIONE DERIVATIVES BIOCON LIMITED (IN) 2003-04-10 WO claimed
US-5733896-A VIRICIDE FOR RETROVIRUS INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) 1998-03-31 US claimed
WO-2024005209-A1 1,4-CINEOLE DERIVATIVE AND INTERMEDIATE THEREOF, HERBICIDE CONTAINING SAME AS ACTIVE INGREDIENT, METHOD FOR USING HERBICIDE, AND METHOD FOR PREPARING AGROCHEMICAL COMPOSITION 北興化学工業株式会社 2024-01-04 WO disclosed
EP-3416959-B1 PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2021-05-12 EP disclosed
US-10874104-B2 Pesticidally active pryazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-12-29 US disclosed
US-20190150441-A1 PESTICIDALLY ACTIVE PRYAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-05-23 US disclosed
CN-106279142-B 5- [[4- [[morpholine -2-yl] methylamino]-5- (trifluoromethyl)-2- pyridyl group] amino] pyrazine-2- nitrile and its treatment use 癌症研究技术有限公司 2019-05-03 CN disclosed
EP-3416959-A1 PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES Syngenta Participations AG (CH) 2018-12-26 EP disclosed
CN-106573898-B Treat and prevent hepatitis b virus infected new pyridazinone and triazinone 豪夫迈·罗氏有限公司 2018-11-09 CN disclosed
CN-104910093-B The contraposition of 4 phenyl contains alcohol oxime ether structure oxazoline compounds and its preparation and the application in terms of worm mite Juncao is prevented and treated 南开大学 2017-09-29 CN disclosed
WO-2017140771-A1 PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-08-24 WO disclosed
EP-0231622-B1 Inhibition of the 5-lipoxygenase pathway SMITHKLINE BEECHAM CORP (US) 1994-08-24 EP disclosed
EP-0404359-B1 Dibenzothiazepine derivatives useful as antispasmodic agents PFIZER LTD (GB) 1994-06-29 EP disclosed
US-RE34201-E Analgesics ANAQUEST, INC. (US) 1993-03-23 US disclosed
US-5071844-A Antispasmodic agents PFIZER INC. (US) 1991-12-10 US disclosed
US-5053411-A Analgesics ANAQUEST, INC. (US) 1991-10-01 US disclosed
EP-0404359-A1 Dibenzothiazepine derivatives useful as antispasmodic agents Pfizer Limited (GB) 1990-12-27 EP disclosed
EP-0396282-A2 N-aryl-N-[4-(heterocyclicalkyl) piperidinyl]amides and pharmaceutical compositions and methods employing such compounds BOC, INC. (US) 1990-11-07 EP disclosed
CN-86108538-A The inhibition of 5-lipoxygenase pathway 1987-07-29 CN disclosed
US-3936461-A Substituted 4-benzylquinolines WARNER-LAMBERT COMPANY (US) 1976-02-03 US disclosed